Dr. Hyeong-Reh Kim receives newly NIH funded grant

Dr. Hyeong-Reh Kim received a newly NIH funded RO1 grant entitled “A Novel AR Degrader in Castrate-Resistant Prostate Cancer” as a 5-year grant with a total award cost of $3,665,981. 

The proposal received the exceptional impact score of 18 and ranked within the top 2 percentile!